Research and development
Key indicators
Selected geographical area: Canada
-
298,850 full-time equivalents16,500(annual change)
-
$46.9 billion9.3%(year-over-year change)
More research and development indicators
Selected geographical area: Canada
-
$16.6 billion4.5%(annual change)
-
$15.1 billion-3.2%(annual change)
Filter results by
Search HelpKeyword(s)
Survey or statistical program
- Federal Science Expenditures and Personnel, Activities in the Social Sciences and Natural Sciences (7)
- Annual Survey of Research and Development in Canadian Industry (5)
- Provincial Government Activities in the Natural Sciences (5)
- Scientific Activities of Provincial Research Organizations, Activities in Natural Sciences and Engineering (4)
- Higher Education Research and Development Estimates (4)
- Research and Development of Canadian Private Non-Profit Organizations (3)
- Biotechnology Use and Development Survey (3)
- Scientific and Technological Activities of Provincial Governments (2)
- Survey of Innovation (2)
- Energy Research and Development Expenditures by Area of Technology (1)
- Energy Research and Development Expenditures - Petroleum Firms (1)
- Survey of Advanced Technology (1)
- Characteristics of Growth Firms (1)
- Gross Domestic Expenditures on Research and Development (1)
Results
All (40)
All (40) (0 to 10 of 40 results)
- Articles and reports: 11-621-M2023016Description: This research study examines the economic impact of the semiconductor industry in Canada in 2020 as it relates to several economic concepts, such as sales and revenue, employment, research and development, and international trade. The study is based on a custom list of 561 firms in the industry provided by Innovation, Science and Economic Development Canada.Release date: 2023-11-10
- Articles and reports: 11-621-M2023001Description: This study examines the economic footprint created by the Canadian research and development pharmaceutical sector on the Canadian economy in 2020, including a focus on the contribution of Innovative Medicines Canada’s members. While the impact of the sector’s medical research is well known, less known are the economic impacts of the sector on the Canadian economy, such as the value generated, the jobs supported and the investments made.Release date: 2023-01-30
- Articles and reports: 11-621-M2022002Description:
This study examines the economic footprint created by the Canadian research and development pharmaceutical sector on the Canadian economy in 2019, including a focus on the contribution of Innovative Medicines Canada’s members. While the impact of the sector’s medical research is well known, less known are the economic impacts of the sector on the Canadian economy, such as the value generated, the jobs supported and the investments made.
Release date: 2022-01-28 - Articles and reports: 11-621-M2021003Description:
This study examines the economic footprint created by the Canadian research and development pharmaceutical sector on the Canadian economy in 2018, including a focus on the contribution of Innovative Medicines Canada’s members. While the impact of the sector’s medical research is well known, less known are the economic impacts of the sector on the Canadian economy, such as the value generated, the jobs supported and the investments made.
Release date: 2021-05-07 - Articles and reports: 11-626-X2016063Description:
This Economic Insights article highlights notable changes in the pace and composition of industrial research and development (R&D) spending in Canada during the 2000-to-2013 period. The analysis is based on historical time series data that conclude with the publication of estimates for reference year 2013. New data on industrial R&D will be released in the coming months. These new survey results begin with estimates for reference year 2014 and reflect conceptual and methodological changes designed to enhance the scope and relevance of the program. Following the introduction of these changes, a study on the break in the time series will be conducted later in 2017. his article highlights trends in industrial R&D spending in advance of the upcoming release of the new data. The analysis underscores the extent to which support for higher R&D spending in more recent years has come from resource-based companies.
Release date: 2017-02-15 - Stats in brief: 88-001-X201100411613Geography: CanadaDescription:
This survey collects data to monitor science and technology related activities in Canada and to support the development of science and technology policy.
Release date: 2011-12-09 - Stats in brief: 88-001-X201000611361Geography: CanadaDescription:
This survey collects data to monitor science and technology related activities in Canada and to support the development of science and technology policy.
Release date: 2010-12-08 - Stats in brief: 88-001-X201000511240Geography: CanadaDescription:
The higher education sector is composed of all universities, colleges of technology and other institutes of postsecondary education, whatever their source of finance or legal status. It also includes all research institutes, experimental stations and clinics operating under the direct control of, or administered by, or associated with higher education establishments.
Release date: 2010-09-08 - 9. Estimates of total spending on research and development in the health field in Canada 1998 to 2009 ArchivedStats in brief: 88-001-X201000311112Geography: CanadaDescription:
This release contains estimates of total spending on research and development (R&D) in the health field in Canada. Tables demonstrate expenditures on health R&D by both performer and funder from 2005 to 2009 preliminary estimates.
Release date: 2010-03-25 - 10. Investment in Intangible Assets in Canada: R&D, Innovation, Brand, and Mining, Oil and Gas Exploration Expenditures ArchivedArticles and reports: 15-206-X2009026Geography: CanadaDescription:
This paper presents estimates of intangible investment in Canada for the purpose of innovation, advertising and resource extraction. It first expands upon work by Beckstead and Gellatly (2003), Baldwin and Hanel (2003), Beckstead and Gellatly (2003), Beckstead and Vinodrai (2003) and Baldwin and Beckstead (2003) who argue that the scope of innovative activity extends beyond research and development (R&D) as defined by the Frascati Manual. It extends the definition of innovative activities to include all scientific and engineering expenditures - regardless of whether they are market-based or produced with a firm. The paper also considers expenditures on intangible items such as brands or resource exploration.
The paper contributes to the existing literature by creating intangible investment estimates (science and engineering knowledge, advertising, mineral exploration by industry) using Statistics Canada's high quality and internally consistent databases. It produces estimates that accord with other intangibles studies (Corrado, Hulten and Sichel 2005, 2006; Jalava, Ahmavarra and Alanen 2007) and shows that traditional R&D type investment estimates account for about a quarter of intangible science and engineering investments.
Release date: 2009-12-02
Data (0)
Data (0) (0 results)
No content available at this time.
Analysis (40)
Analysis (40) (0 to 10 of 40 results)
- Articles and reports: 11-621-M2023016Description: This research study examines the economic impact of the semiconductor industry in Canada in 2020 as it relates to several economic concepts, such as sales and revenue, employment, research and development, and international trade. The study is based on a custom list of 561 firms in the industry provided by Innovation, Science and Economic Development Canada.Release date: 2023-11-10
- Articles and reports: 11-621-M2023001Description: This study examines the economic footprint created by the Canadian research and development pharmaceutical sector on the Canadian economy in 2020, including a focus on the contribution of Innovative Medicines Canada’s members. While the impact of the sector’s medical research is well known, less known are the economic impacts of the sector on the Canadian economy, such as the value generated, the jobs supported and the investments made.Release date: 2023-01-30
- Articles and reports: 11-621-M2022002Description:
This study examines the economic footprint created by the Canadian research and development pharmaceutical sector on the Canadian economy in 2019, including a focus on the contribution of Innovative Medicines Canada’s members. While the impact of the sector’s medical research is well known, less known are the economic impacts of the sector on the Canadian economy, such as the value generated, the jobs supported and the investments made.
Release date: 2022-01-28 - Articles and reports: 11-621-M2021003Description:
This study examines the economic footprint created by the Canadian research and development pharmaceutical sector on the Canadian economy in 2018, including a focus on the contribution of Innovative Medicines Canada’s members. While the impact of the sector’s medical research is well known, less known are the economic impacts of the sector on the Canadian economy, such as the value generated, the jobs supported and the investments made.
Release date: 2021-05-07 - Articles and reports: 11-626-X2016063Description:
This Economic Insights article highlights notable changes in the pace and composition of industrial research and development (R&D) spending in Canada during the 2000-to-2013 period. The analysis is based on historical time series data that conclude with the publication of estimates for reference year 2013. New data on industrial R&D will be released in the coming months. These new survey results begin with estimates for reference year 2014 and reflect conceptual and methodological changes designed to enhance the scope and relevance of the program. Following the introduction of these changes, a study on the break in the time series will be conducted later in 2017. his article highlights trends in industrial R&D spending in advance of the upcoming release of the new data. The analysis underscores the extent to which support for higher R&D spending in more recent years has come from resource-based companies.
Release date: 2017-02-15 - Stats in brief: 88-001-X201100411613Geography: CanadaDescription:
This survey collects data to monitor science and technology related activities in Canada and to support the development of science and technology policy.
Release date: 2011-12-09 - Stats in brief: 88-001-X201000611361Geography: CanadaDescription:
This survey collects data to monitor science and technology related activities in Canada and to support the development of science and technology policy.
Release date: 2010-12-08 - Stats in brief: 88-001-X201000511240Geography: CanadaDescription:
The higher education sector is composed of all universities, colleges of technology and other institutes of postsecondary education, whatever their source of finance or legal status. It also includes all research institutes, experimental stations and clinics operating under the direct control of, or administered by, or associated with higher education establishments.
Release date: 2010-09-08 - 9. Estimates of total spending on research and development in the health field in Canada 1998 to 2009 ArchivedStats in brief: 88-001-X201000311112Geography: CanadaDescription:
This release contains estimates of total spending on research and development (R&D) in the health field in Canada. Tables demonstrate expenditures on health R&D by both performer and funder from 2005 to 2009 preliminary estimates.
Release date: 2010-03-25 - 10. Investment in Intangible Assets in Canada: R&D, Innovation, Brand, and Mining, Oil and Gas Exploration Expenditures ArchivedArticles and reports: 15-206-X2009026Geography: CanadaDescription:
This paper presents estimates of intangible investment in Canada for the purpose of innovation, advertising and resource extraction. It first expands upon work by Beckstead and Gellatly (2003), Baldwin and Hanel (2003), Beckstead and Gellatly (2003), Beckstead and Vinodrai (2003) and Baldwin and Beckstead (2003) who argue that the scope of innovative activity extends beyond research and development (R&D) as defined by the Frascati Manual. It extends the definition of innovative activities to include all scientific and engineering expenditures - regardless of whether they are market-based or produced with a firm. The paper also considers expenditures on intangible items such as brands or resource exploration.
The paper contributes to the existing literature by creating intangible investment estimates (science and engineering knowledge, advertising, mineral exploration by industry) using Statistics Canada's high quality and internally consistent databases. It produces estimates that accord with other intangibles studies (Corrado, Hulten and Sichel 2005, 2006; Jalava, Ahmavarra and Alanen 2007) and shows that traditional R&D type investment estimates account for about a quarter of intangible science and engineering investments.
Release date: 2009-12-02
Reference (0)
Reference (0) (0 results)
No content available at this time.
- Date modified: